Navigation Links
Lexicon to Present at Two Major Healthcare Investor Conferences
Date:6/3/2010

THE WOODLANDS, Texas, June 3 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that Alan J. Main, Ph.D., Lexicon's executive vice president of pharmaceutical research, will present at two investor conferences next week in New York. Dr. Main will present at the 9th Annual Needham Healthcare Conference on Wednesday, June 9, 2010 10 a.m. Eastern Time; and at the Jefferies 2010 Global Life Sciences Conference on Friday, June 11, 2010 at 11 a.m. Eastern Time.  Investors can access a webcast of the Jefferies Conference presentation at www.lexpharma.com.

Needham & Company's Annual Healthcare Conference is a forum for institutional investors and venture capital firms to hear the latest updates from senior management teams of both public and private companies in the biotechnology, specialty pharmaceuticals, medical technology,
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Lexicon Announces Pricing of Common Stock in Public Offering
2. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Fourth Quarter and Full Year Financial Results
3. Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock
4. Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
5. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009
6. Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
7. Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
8. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
9. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009
10. Lexicon Pharmaceuticals 2008 Annual Report to Stockholders Available Online
11. Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2013)... The topics that will be covered ... framework, scrum roles, scrum meetings, scrum artifacts, and scrum ... (8 PDUs) for attending them. , These trainings are ... directors. It is also ideal for those who will ... the software industry or those who want to explore ...
(Date:6/14/2013)... The OpenClinica Global Conference ... this year with Formedix CEO, Mark Wheeldon presenting as ... attendees a deeper insight into the future developments at ... as Formedix to develop innovative solutions. , The conference ... about OpenClinica, hear real-life case studies and discover more ...
(Date:6/14/2013)... EASTON, Mass. , June 14, 2013  Pressure ... announced that it has closed the third and final ... Preferred Stock and Warrants (the "Series J Private Placement").  ... 6 and $156,900 on March 28, 2013), the Company ... Series J Private Placement, slightly over its goal of ...
(Date:6/13/2013)... Eagle Biosciences is proud to ... Calprotectin ELISA assay kit that offers ... (1-2000 µg/g stool). The Calprotectin ELISA assay kit ... human Calprotectin (neutrophil cytoplasmic protein s100A8/A9, MRP 8/14) ... gastrointestinal assay line which already includes Alpha 1 ...
Breaking Biology Technology:Affordable Scrum Trainings in Chicago on July 12th 2013 by Conscires Agile Practices 2Affordable Scrum Trainings in Chicago on July 12th 2013 by Conscires Agile Practices 3Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 2Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 3Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 2Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 3Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 4Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 5Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit 2
... requires substantial reform because it too often fails to support ... to new research from the Economic and Social Research Council ... UN, which has designated 2012 the International Year of Sustainable ... Development Mechanism (CDM), under which companies are allocated tradable credits ...
... National Nanotechnology Initiative (NNI) and the Oregon Nanoscience and ... regional, state, and local (RSL) nanotechnology initiatives. ... April 30 Where: Portland, Oregon at the ... OR Who: Leaders of regional, state, and ...
... 2012 The Foundation of UMDNJ, an affiliate of ... biomarkers grant through the Bill & Melinda Gates Foundation,s ... seeks to overcome persistent bottlenecks in creating new tools ... With the grant, Dr. David Alland, ...
Cached Biology Technology:UN emission market needs urgent reform 2Registration now open: 2012 Regional, State, and Local Initiatives in Nanotechnology 2Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant 2Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant 3
(Date:6/17/2013)... their food may turn out to be just as important ... of St. Michael,s Hospital. , The study, led by ... association between poor eating habits in kids ages three to ... cholesterol, putting them at risk for cardiovascular disease later in ... Medical Association Journal today. , "We know that ...
(Date:6/17/2013)... , June 17, 2013 As mobile ... need to secure them grows exponentially, and biometric ... report from Heavy Reading Insider ( ... Heavy Reading ( www.heavyreading.com ). ... the market for biometric authentication on smartphones, analyzing ...
(Date:6/17/2013)... MD (June 17, 2013) The AGA Research Foundation ... in the future of gastroenterology with the 2013 AGA-Horizon ... Student Abstract Prizes. , "In its third year, this ... who are embarking on promising careers in basic and ... of the AGA Research Foundation. "We are extremely proud ...
Breaking Biology News(10 mins):Poor eating behaviors may put preschoolers at risk for later health problems 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3Horizon Pharma Abstract Prizes recognize promising fellows and students 2
... ethanol production has increased dramatically in recent years ... increased. New U.S. government policies require major increases ... a viable cellulosic ethanol industry, expanded grain ethanol ... acres in the near term, with unintended negative ...
... the first pervasive rule of evolution. In ... Academy of Sciences researchers have found evidence which suggests ... Looking back through the last 550 million ... the team investigated the different evolutionary branches of the ...
... Oregon,s Jim Hutchison already holds three patents in the ... in organizations that promote the technology,s potential in materials ... scientist, however, also embraces a strong call for exploring ... be many, and for designing new materials with reduced ...
Cached Biology News:Fueling ethanol production while protecting water quality 2Fueling ethanol production while protecting water quality 3First 'rule' of evolution suggests that life is destined to become more complex 2Think green, UO's Hutchison says, to reduce nanotech hazards 2Think green, UO's Hutchison says, to reduce nanotech hazards 3
...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
Goat anti-VAV2 Class: Antibody Product Group: Miscellaneous Antibody...
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
Biology Products: